- Author: Insu Choi, Hwa-Jin Cho, Min-Chul Kim, Yong-Hun Jung, Do-Wan Kim, Kyo-Seon Lee, Kyung-Woon Jeung, Sang-Gi Oh, In-Seok Jeong
- Date: 2024/09/01
- Journal: ASAIO Journal;70(supplement4);20
- PMID:
- PMCID:
- DOI:10.1097/01.mat.0001069848.33321.52
Abstract
Background: Statin therapy is essential for the treatment of acute coronary syndrome (ACS). We investigated the effect of statin therapy on survival in Extracorporeal Membrane Oxygenation (ECMO) patients with ACS complicated by cardiogenic shock or cardiac arrest. Methods: We respectively reviewed the medical records of patients who underwent ECMO support with ACS between January 2015 and June 2020. The primary outcome was in-hospital mortality. The predictors of in-hospital mortality were determined by a Cox proportional hazard regression model. Results: A total 138 patients (mean age: 66.4±10.5) with ACS were treated by venoarterial (VA) ECMO. Mean duration of ECMO support was 6.2±7.3 days. The overall survival rate to hospital discharge was 45.7%(n= 63). Fifty-nine patients (42.8%) received statin therapy for more than 4 days. On multivariate analysis, statin therapy more than 4days …